NCT05646862 2026-02-05
INAVO121
Hoffmann-La Roche
Phase 3 Active not recruiting
Hoffmann-La Roche
Pfizer
AstraZeneca
Washington University School of Medicine
Centro di Riferimento Oncologico - Aviano
Eli Lilly and Company
Eli Lilly and Company
GlaxoSmithKline
M.D. Anderson Cancer Center